| 000 | 01433 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514165011.0 | ||
| 264 | 0 | _c20040227 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0030-2414 | ||
| 024 | 7 |
_a10.1159/000074641 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRaderer, Markus | |
| 245 | 0 | 0 |
_aRituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. _h[electronic resource] |
| 260 |
_bOncology _c2003 |
||
| 300 |
_a306-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntigens, CD20 _xdrug effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _ximmunology |
| 650 | 0 | 4 |
_aEpitopes, B-Lymphocyte _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aLymphoma, B-Cell, Marginal Zone _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aJäger, Gerald | |
| 700 | 1 | _aBrugger, Stefan | |
| 700 | 1 | _aPüspök, Andreas | |
| 700 | 1 | _aFiebiger, Wolfgang | |
| 700 | 1 | _aDrach, Johannes | |
| 700 | 1 | _aWotherspoon, Andrew | |
| 700 | 1 | _aChott, Andreas | |
| 773 | 0 |
_tOncology _gvol. 65 _gno. 4 _gp. 306-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000074641 _zAvailable from publisher's website |
| 999 |
_c14436599 _d14436599 |
||